肺大细胞神经内分泌癌的<sup>18</sup>F-FDG PET/CT表现

柳卫; 李天女; 范磊; 丁重阳; 柳卫; 李天女; 范磊; 丁重阳

doi:10.3760/cma.j.issn.1673-4114.2018.06.002

[1]

Kasajima A, Ishikaw a Y, Iwata A, et al. Inflammation and PD-L1 expression in pulmonary neuroendocrine tumors[J]. Endocr Relat Cancer, 2018, 25(3):339-350. DOI:10.1530/ERC-17-0427.

[2]

Derks JL, Leblay N, Thunnissen E, et al. Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome[J]. Clin Cancer Res, 2018, 24(1):33-42. DOI:10.1158/1078-0432.CCR-17-1921.

[3]

Cattoni M, Vallières E, Brown LM, et al. Improvement in TNM staging of pulmonary neuroendocrine tumors requires histology and regrouping of tumor size[J]. J Thorac Cardiovasc Surg, 2018, 155(1):405-413. DOI:10.1016/j.jtcvs.2017.08.102.

[4]

Hoton D, Humblet Y, Libbrecht L. Phenotypic variation of an ALK-positive large-cell neuroendocrine lung carcinoma with carcinoid morphology during treatment with ALK inhibitors[J]. Histopathology, 2018, 72(4):707-710. DOI:10.1111/his.13388.

[5]

Akata S, Okada S, Maeda J, et al. Computed tomographic findings of large cell neuroendocrine carcinoma of the lung[J]. Clin Imaging, 2007, 31(6):379-84. DOI:10.1016/j.clinimag.2007.04.027.

[6]

郭健, 叶兆祥, 冯小伟, 等.肺大细胞神经内分泌癌的MSCT表现[J].中国医学影像技术, 2013, 29(1):79-83.
Guo J, Ye ZX, Feng XW, et al. MSCT findings of lung large cell neuroendocrine carcinoma[J]. Chin J Med Imaging Technol, 2013, 29(1):79-83.

[7]

金民山, 张俊, 姜一逸, 等. ¹⁸F-FDG PET/CT在不明原发灶肿瘤中的临床应用价值[J].国际放射医学核医学杂志, 2017, 41(2):94-97. DOI:10.3760/cma.j.issn.1673-4114.2017.02.003.
Jin MS, Zhang J, Jiang YY, et al. Clinical value of ¹⁸F-FDG PET/CT in cancer of unknown primary[J]. Int J Radiat Med Nucl Med, 2017, 41(2):94-97. DOI:10.3760/cma.j.issn.1673-4114. 2017.02. 003.

[8]

Lee KW, Lee Y, Oh SW, et al. Large cell neuroendocrine carcinoma of the lung:CT and FDG PET findings[J]. Eur J Radiol, 2015, 84(11):2332-2338. DOI:10.1016/j.ejrad.2015.07.033.

[9]

Kaira K, Murakami H, Endo M, et al. Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors[J]. Anticancer Res, 2013, 33(10):4219-4228.

[10]

严振辉, 柳学国, 何亚奇, 等.肺大细胞神经内分泌癌的临床影像学特点与诊断(附22例分析)[J].现代医用影像学, 2015, 24(3):375-379.
Yan ZH, Liu XG, He YQ, et al. Clinical imaging and characteristics diagnosis of pulmonary large cell neuroendocrine carcinoma (Analysis of 22 cases)[J]. Mod Med Imagel, 2015, 24(3):375-379.

[11]

钱哲, 胡瑛, 郑华, 等.肺大细胞神经内分泌癌22例临床分析[J].中国肺癌杂志, 2016, 19(2):82-87. DOI:10.3779/j.issn.1009-3419.2016.02.05.
Qian Z, Hu Y, Zheng H, et al. Clinical analysis of 22 cases of pulmonary large cell neuroendocrine cancer[J]. Chin J Lung Cancer, 2016, 19(2):82-87. DOI:10.3779/j.issn.1009-3419. 2016. 02.05.

[12]

Kaseda K, Asakura K, Kazama A, et al. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage Ⅰ Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography[J]. World J Surg, 2016, 40(12):2976-2983. DOI:10.1007/s00268-016-3652-5.